Targeting huntingtin as a therapeutic strategy for Huntington’s disease

Name: Targeting huntingtin as a therapeutic strategy for Huntington’s disease — Rooted in STEM
Start: 2022-02-02T09:00:00-0500
End: 2022-02-02T21:30:00-0500

Wednesday, February 2, 2022
9:00 AM 9:30 PM

Google Calendar ICS

Stanford & Northwestern Proteostasis Consortium Weekly Seminar:

Come listen to Dr. GILLIAN BATES (UCL QUEEN SQUARE INSTITUTE OF NEUROLOGY) talk about ‘Targeting huntingtin as a therapeutic strategy for Huntington’s disease’.

Registration is free! Sign up to get the link here.

January 26

Beyond just targeting: Ubiquitin modulates the conformational changes and substrate degradation of the 26S proteasome

February 9

Targeting huntingtin as a therapeutic strategy for Huntington’s disease

Beyond just targeting: Ubiquitin modulates the conformational changes and substrate degradation of the 26S proteasome

Solution NMR Reveals the Critical Role of Dynamics in Driving the Function of Molecular Machines

Rooted in STEM